Clinical scores | TUS therapy group (pre-treatment) (n = 15) | TUS therapy group (post-treatment) (n = 15) | p value | Significance |
Tenderness grading scale [median (range)] | 2 (2–3) | 2 (1–3) | < 0.001 | Very HSσ |
VAS [median (range)] | 8 (5–10) | 2 (1–7) | < 0.001 | Very HSσ |
PRTEE score (mean ± SD) | 48.13 ± 9.58 | 33.27 ± 8.40 | < 0.001 | Very HSσ |
US findings | US findings pre-treatment (TUS group) | US findings post-treatment (TUS group) | p value | Significance |
Hypoechoic area in CET (+ve/−ve) no. | 3/12 | 7/8 | 0.020 | S§ |
Disturbed fibrillar pattern (+ve/−ve) no. | 11/4 | 7/8 | 0.136 | NS§ |
Tendon thickness (cm) (mean ± SD) | 0.55 ± 0.07 | 0.53 ± 0.07 | 0.026 | S* |
Enthesophyte (+ve/−ve) no. | 8/7 | 7/8 | 0.715 | NS§ |
Osteophyte (+ve/−ve) no. | 3/12 | 3/12 | 1 | NS§ |
Calcification (+ve/−ve) no. | 3/12 | 2/13 | 1 | NS§ |
Bone surface irregularity/erosion (+ve/−ve) no. | 10/5 | 9/6 | 0.705 | NS¶ |
Tendon tear (+ve/−ve) no. | 1/14 | 1/14 | 1 | NS§ |
Power Doppler signal (+ve/−ve) no. | 4/11 | 1/14 | 0.330 | NS¶ |